Invention Grant
- Patent Title: Stabilisation of radiopharmaceutical precursors
-
Application No.: US14258247Application Date: 2014-04-22
-
Publication No.: US09969761B2Publication Date: 2018-05-15
- Inventor: Torild Wickstrom , Dirk-Jan In't Veld , Nigel John Osborn , Julian Grigg , Anthony Wilson
- Applicant: GE HEALTHCARE LIMITED , GE HEALTHCARE AS
- Applicant Address: NO Oslo GB Buckinghamshire
- Assignee: GE HEALTHCARE AS,GE HEALTHCARE LIMITED
- Current Assignee: GE HEALTHCARE AS,GE HEALTHCARE LIMITED
- Current Assignee Address: NO Oslo GB Buckinghamshire
- Agency: Wood IP LLC
- Priority: GB0428020.2 20041222
- Main IPC: C07H13/04
- IPC: C07H13/04 ; C07H1/00

Abstract:
The present invention relates to a method for improving stability of non fluoridated sugar derivatives, and in particular glucose derivatives such as 1,3,4,6-tetra-O-acetyl-2-O-trifluoromethanesulfonyl-β-D-mannopyranose which are used as precursors for production of radiofluoridated sugar derivatives for use in in vivo imaging procedures such as positron emission tomography (PET). The method comprises storing the non fluoridated sugar derivative in an organic solvent. The resultant formulations of the non fluoridated sugar derivative and cassettes for automated synthesis apparatus comprising the same are also claimed.
Public/Granted literature
- US20150018541A1 STABILISATION OF RADIOPHARMACEUTICAL PRECURSORS Public/Granted day:2015-01-15
Information query